News Sentiment

CLOV sentiment intelligence

Clover Health Investments Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 52 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Healthcare Plans Read-through group
Latest close 4.44 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

86/100 classification confidence.

Company focus 52

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-15.6% over one week, -6.1% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Issuer (NASDAQ: CLOV) plans 10,192-share Class A sale under 10b5-1 plan

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 86/100 classification
One-week reaction -15.6% Price reacting lower
Trend fit Trend active -6.1% over four weeks
Fair value 84.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 41
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 52
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 15
Market source 9
Investing.com 9
simplywall.st 6
TradingView 4
Investing.com Australia 3
Motley Fool 2
GlobeNewswire 1

Event Lens

What the news is about

Classified themes
Market update 38
Earnings 7
Analyst action 4
Deals and strategy 1
Guidance 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 52
Investing.com Direct company coverage

Clover Health Medicare Advantage CEO sells $11,157 in shares

Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp. (NASDAQ:CLOV), sold 2,384 shares of the company's Class A Common Stock for a total of $11,157 on July 8, 2026. This transaction was part of a pre-arranged trading plan. Following the sale, Reynoso sti

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 21:45
Source
Investing.com
Stock Titan Direct company coverage

Clover Health (CLOV) Medicare Advantage CEO sells small stake under Rule 10b5-1 plan

Clover Health Investments, Corp. CEO of Medicare Advantage, Jamie L. Reynoso, sold 2,384 shares of Class A Common Stock at $4.68 per share. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 12, 2026, and leaves Reynoso with 2,832,598 sh

Tone
Negative 40/100
Event
Deals and strategy
Published
09 Jul 2026 20:45
Source
Stock Titan
Stock Titan Direct company coverage

Jamie Reynoso 10b5-1 sales listed in CLOV Form 144 (CLOV)

A recently filed Form 144 for Clover Health Investments, Corp. (CLOV) details multiple 10b5-1 sales by Jamie Reynoso. The filing, dated July 6, 2026, lists sales on March 18, 2026, June 11, 2026, June 15, 2026, and June 17, 2026, along with Restricted Stock Units dated July 3, 20

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 01:12
Source
Stock Titan
Stock Titan Direct company coverage

Clover Health (CLOV) exec sells 6,229 shares in mandated tax-withholding trade

Jamie L. Reynoso, CEO of Medicare Advantage for Clover Health (CLOV), sold 6,229 shares of Class A Common Stock at $5.26 per share. This transaction was not a discretionary trade but a "sell to cover" action to meet tax withholding obligations related to the vesting of restricted

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 00:36
Source
Stock Titan
Investing.com Direct company coverage

Clover Health Medicare Advantage CEO Reynoso sells $32,764 in stock

Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp., sold 6,229 shares of Class A Common Stock for $32,764 on July 6, 2026. This sale was a "sell to cover" transaction to fulfill tax withholding obligations tied to the vesting of restricted stock units

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 22:39
Source
Investing.com
Stock Titan Direct company coverage

Clover Health (CLOV) CEO’s 313,476-share sale tied to RSU tax withholding

Clover Health Investments, Corp. (CLOV) CEO Andrew Toy sold 313,476 shares of Class A common stock at $5.32 per share. This sale was explicitly to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) and was a non-discretionary "sell to c

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 00:40
Source
Stock Titan
Investing.com Nigeria Direct company coverage

Clover Health CEO Andrew Toy sells $1.67 million in stock By Investing.com

Clover Health CEO Andrew Toy sold 313,476 shares of Class A Common Stock for $1.67 million to cover tax withholding obligations related to vested restricted stock units. This sale was a "sell to cover" transaction and not a discretionary trade. The stock, trading near its 52-week

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 22:41
Source
Investing.com Nigeria
Investing.com Direct company coverage

Clover Health CEO Andrew Toy sells $1.67 million in stock

Clover Health CEO Andrew Toy sold 313,476 shares of Class A Common Stock for $1.67 million to cover tax obligations related to restricted stock units. This sale was a mandatory "sell to cover" transaction and not discretionary. The company recently reported Q1 2026 revenue of $74

Tone
Neutral 50/100
Event
Earnings
Published
01 Jul 2026 22:40
Source
Investing.com
Stock Titan Direct company coverage

[144] CLOVER HEALTH INVESTMENTS, CORP. /DE SEC Filing

This SEC filing details a Form 144 notice of proposed sale of securities for Clover Health Investments, Corp. (CLOV). The filing indicates an individual plans to sell 309,558 shares of Class A Common Stock, acquired through Restricted Stock Units as compensation, with an aggregat

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 20:39
Source
Stock Titan
TradingView Direct company coverage

ETFs Investing in Clover Health Investments Corp. Class A Stocks

This article provides a list of exchange-traded funds (ETFs) that hold Clover Health Investments Corp. Class A stocks. The funds are sorted by market value and include details such as issuer, management style, focus, expense ratio, assets under management (AUM), and price perform

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 20:09
Source
TradingView
Stock Titan Direct company coverage

CLOV SEC Filings - Clover Health Investments Corp 10-K, 10-Q, 8-K Forms

This page provides a comprehensive resource for investors to access Clover Health Investments (CLOV) SEC filings, including annual reports (10-K), quarterly reports (10-Q), and material event reports (8-K). It details recent insider transaction activity, such as share withholding

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 04:28
Source
Stock Titan
TradingView Direct company coverage

7QD Forecast — Price Target — Prediction for 2027

The article provides a forecast and price target for Clover Health Investments Corp. Class A (7QD) stock based on analyst opinions. It details maximum and minimum price estimates, historical price data, earnings information, and financial performance for the company, including re

Tone
Positive 61/100
Event
Analyst action
Published
26 Jun 2026 10:40
Source
TradingView
TradingView Direct company coverage

Clover Health Investments Corp. Class A Actuals & Estimates (NASDAQ:CLOV)

This article provides an overview of Clover Health Investments Corp. (NASDAQ: CLOV), detailing its financial actuals and estimates. It covers the company's current stock price, historical highs and lows, market capitalization, and volatility. Additionally, it includes analysts' f

Tone
Positive 62/100
Event
Market update
Published
26 Jun 2026 02:42
Source
TradingView
TradingView Direct company coverage

Clover Health Investments Corp. Class A Actuals & Estimates (BX:CLOV)

This article provides financial actuals and estimates for Clover Health Investments Corp. Class A (CLOV) traded on the BX Swiss exchange. It details analyst price targets, upcoming earnings dates, past earnings and revenue figures, and confirms that CLOV does not pay dividends. T

Tone
Positive 65/100
Event
Earnings
Published
25 Jun 2026 23:09
Source
TradingView